Eschenfeldt William H, Maltseva Natalia, Stols Lucy, Donnelly Mark I, Gu Minyi, Nocek Boguslaw, Tan Kemin, Kim Youngchang, Joachimiak Andrzej
Midwest Center for Structural Genomics, Biosciences Division, Argonne National Laboratory, Bldg. 202/Rm. BE111, 9700 South Cass Avenue, Argonne, IL 60439, USA.
J Struct Funct Genomics. 2010 Mar;11(1):31-9. doi: 10.1007/s10969-010-9082-y. Epub 2010 Mar 6.
High-throughput structural genomics projects seek to delineate protein structure space by determining the structure of representatives of all major protein families. Generally this is accomplished by processing numerous proteins through standardized protocols, for the most part involving purification of N-terminally His-tagged proteins. Often proteins that fail this approach are abandoned, but in many cases further effort is warranted because of a protein's intrinsic value. In addition, failure often occurs relatively far into the path to structure determination, and many failed proteins passed the first critical step, expression as a soluble protein. Salvage pathways seek to recoup the investment in this subset of failed proteins through alternative cloning, nested truncations, chemical modification, mutagenesis, screening buffers, ligands and modifying processing steps. To this end we have developed a series of ligation-independent cloning expression vectors that append various cleavable C-terminal tags instead of the conventional N-terminal tags. In an initial set of 16 proteins that failed with an N-terminal appendage, structures were obtained for C-terminally tagged derivatives of five proteins, including an example for which several alternative salvaging steps had failed. The new vectors allow appending C-terminal His(6)-tag and His(6)- and MBP-tags, and are cleavable with TEV or with both TEV and TVMV proteases.
高通量结构基因组学项目旨在通过确定所有主要蛋白质家族代表的结构来描绘蛋白质结构空间。一般来说,这是通过标准化方案处理大量蛋白质来实现的,在大多数情况下涉及纯化N端带有组氨酸标签的蛋白质。通常,未能通过这种方法的蛋白质会被舍弃,但在许多情况下,由于蛋白质本身的价值,进一步的努力是值得的。此外,失败往往发生在结构确定过程的较后期,许多失败的蛋白质通过了第一个关键步骤,即可溶性蛋白质的表达。挽救途径试图通过替代克隆、嵌套截短、化学修饰、诱变、筛选缓冲液、配体和修改处理步骤来挽回对这部分失败蛋白质的投入。为此,我们开发了一系列不依赖连接的克隆表达载体,这些载体附加各种可切割的C端标签,而不是传统的N端标签。在最初一组16个因N端附加物而失败的蛋白质中,获得了5种蛋白质C端标记衍生物的结构,其中包括一个经过几个替代挽救步骤均失败的例子。新载体允许附加C端His(6)-标签、His(6)-和MBP-标签,并且可用TEV或TEV和TVMV蛋白酶进行切割。